Scholars@Duke

Public sector must develop drugs for neglected diseases.

Publication ,  Journal Article
Yamey, G
Published in: BMJ (Clinical research ed.)
March 2002
Published version (DOI)

Duke Scholars

Gavin Mark Yamey
Author Gavin Mark Yamey Duke Global Health Institute

Published In

BMJ (Clinical research ed.)

DOI

10.1136/bmj.324.7339.698/b

EISSN

1756-1833

ISSN

0959-8138

Publication Date

March 2002

Volume

324

Issue

7339

Start / End Page

698

Related Subject Headings

  • Public Sector
  • Humans
  • General & Internal Medicine
  • Drug Industry
  • Developing Countries
  • Communicable Diseases
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yamey, G. (2002). Public sector must develop drugs for neglected diseases. BMJ (Clinical Research Ed.), 324(7339), 698. https://doi.org/10.1136/bmj.324.7339.698/b
Yamey, Gavin. “Public sector must develop drugs for neglected diseases.” BMJ (Clinical Research Ed.) 324, no. 7339 (March 2002): 698. https://doi.org/10.1136/bmj.324.7339.698/b.
Yamey G. Public sector must develop drugs for neglected diseases. BMJ (Clinical research ed). 2002 Mar;324(7339):698.
Yamey, Gavin. “Public sector must develop drugs for neglected diseases.” BMJ (Clinical Research Ed.), vol. 324, no. 7339, Mar. 2002, p. 698. Epmc, doi:10.1136/bmj.324.7339.698/b.
Yamey G. Public sector must develop drugs for neglected diseases. BMJ (Clinical research ed). 2002 Mar;324(7339):698.

Published In

BMJ (Clinical research ed.)

DOI

10.1136/bmj.324.7339.698/b

EISSN

1756-1833

ISSN

0959-8138

Publication Date

March 2002

Volume

324

Issue

7339

Start / End Page

698

Related Subject Headings

  • Public Sector
  • Humans
  • General & Internal Medicine
  • Drug Industry
  • Developing Countries
  • Communicable Diseases
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 1117 Public Health and Health Services